Luca Sgarra

Impact of GLP1Ra and SGLT2i on atrial fibrillation in overweight, non-diabetic patients: A meta-analysis of randomized evidence

Sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1Ra) are breakthrough therapies for type 2 diabetes (T2DM), exhibiting pleiotropic effects. Their clinical use has expanded to lower-risk populations, including overweight and ob...

Cardiopulmonary Support During Catheter Ablation of Ventricular Arrhythmias: Long-Term Results from a Single-Center Experience

Extracorporeal membranes oxygenation (ECMO) has been proposed as a useful tool to support ablation of unstable ventricular arrhythmias (VAs). The aim of this study is to assess the clinical outcome of cardiopulmonary support of VAs catheter ablation during a long-term follow-up....